Acylcarnitines that accumulate through disordered carnitine metabolism directly inhibit the surface activity of pulmonary surfactants and are considered risk factors for increased lung injury due to a second hit, such as respiratory tract infection, sepsis, or inhalation of toxins, in patients with dysregulated FAO [304, 305]
Its full potential in consumer skincare is still being studied, especially regarding long-term safety and efficacy
The independent variables in this study were: Supplementation protocol: Participants received either L-carnitine or placebo in each session, with the order randomly assigned
Recent advances in microbiome research have opened new avenues for prevention and intervention, focusing on how gut microbial communities influence immune, metabolic, and neural pathways relevant to CFS/ME
GSH/GSSG-Glo Assay Overview